• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二代H1受体拮抗剂西替利嗪在幼儿中的药代动力学评估。

A pharmacokinetic evaluation of the second-generation H1-receptor antagonist cetirizine in very young children.

作者信息

Desager J P, Dab I, Horsmans Y, Harvengt C

机构信息

Department of Internal Medicine, Université Catholique de Louvain, Belgium.

出版信息

Clin Pharmacol Ther. 1993 Apr;53(4):431-5. doi: 10.1038/clpt.1993.47.

DOI:10.1038/clpt.1993.47
PMID:8477559
Abstract

The pharmacokinetics of the second-generation H1-receptor antagonist cetirizine was studied in eight children younger than 4 years of age who were treated with a single dose of cetirizine solution (5 mg). These children were hospitalized with suspected allergic respiratory problems or recurrent respiratory tract infections. Blood samples were collected at 1/2, 1, 1 1/2, 2, 4, 6, 8, 12, and 24 hours, and a 24-hour urine collection was performed in five of the samples. The findings obtained in children were compared with those obtained in 16 healthy young adults (mean +/- SD, 24.6 +/- 4.1 years) who received a single 20 mg dose. Cetirizine was absorbed more slowly in children (p = 0.006; mean +/- SD, 1.44 +/- 1.12 hours) than in adults (0.62 +/- 0.22 hours). The plasma elimination half-life of cetirizine was significantly shorter in children (p < 0.001; 4.91 +/- 0.6 hours) than in adults (8.6 +/- 2.1 hours), and the clearance rate was significantly higher in children (p < 0.001; 1.48 +/- 0.41 ml/min/kg) than in adults (0.80 +/- 0.17 ml/min/kg). Urinary excretion of unchanged cetirizine was significantly lower in children (p < 0.001; 37.8% +/- 5.2%; n = 5) than in adults (57.7% +/- 11.8%). Therefore the metabolism of cetirizine is faster in young children than in adults. This effect must be taken into account in future pharmacodynamic studies in this age group.

摘要

在8名4岁以下因疑似过敏性呼吸道问题或反复呼吸道感染而住院的儿童中,研究了第二代H1受体拮抗剂西替利嗪的药代动力学。这些儿童接受了单剂量西替利嗪溶液(5毫克)治疗。在给药后1/2、1、1 1/2、2、4、6、8、12和24小时采集血样,并对其中5份样本进行了24小时尿液收集。将儿童的研究结果与16名接受单剂量20毫克西替利嗪的健康年轻成年人(平均±标准差,24.6±4.1岁)的结果进行比较。西替利嗪在儿童体内的吸收比成人更慢(p = 0.006;平均±标准差,1.44±1.12小时对比0.62±0.22小时)。西替利嗪的血浆消除半衰期在儿童中显著短于成人(p < 0.001;4.91±0.6小时对比8.6±2.1小时),清除率在儿童中显著高于成人(p < 0.001;1.48±0.41毫升/分钟/千克对比0.80±0.17毫升/分钟/千克)。儿童中未变化的西替利嗪尿排泄显著低于成人(p < 0.001;37.8%±5.2%;n = 5对比57.7%±11.8%)。因此,西替利嗪在幼儿中的代谢比成人更快。在该年龄组未来的药效学研究中必须考虑到这一效应。

相似文献

1
A pharmacokinetic evaluation of the second-generation H1-receptor antagonist cetirizine in very young children.第二代H1受体拮抗剂西替利嗪在幼儿中的药代动力学评估。
Clin Pharmacol Ther. 1993 Apr;53(4):431-5. doi: 10.1038/clpt.1993.47.
2
Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers.
Clin Pharmacol Ther. 1997 Mar;61(3):325-30. doi: 10.1016/S0009-9236(97)90165-X.
3
Pharmacokinetics of cetirizine in 2- to 6-year-old children.西替利嗪在2至6岁儿童中的药代动力学。
Int J Clin Pharmacol Ther. 1995 Jun;33(6):340-4.
4
Cetirizine pharmacokinetics and pharmacodynamics in primary biliary cirrhosis.西替利嗪在原发性胆汁性肝硬化中的药代动力学和药效学。
J Clin Pharmacol. 1993 Oct;33(10):949-54. doi: 10.1002/j.1552-4604.1993.tb01928.x.
5
Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.组胺H1受体拮抗剂治疗的药代动力学优化
Clin Pharmacokinet. 1991 Nov;21(5):372-93. doi: 10.2165/00003088-199121050-00005.
6
Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders.西替利嗪。对其药理特性及在特定过敏性疾病中的治疗用途的重新评估。
Drugs. 1993 Dec;46(6):1055-80. doi: 10.2165/00003495-199346060-00008.
7
Pharmacokinetics of cetirizine in healthy cats.西替利嗪在健康猫体内的药代动力学
Am J Vet Res. 2008 May;69(5):670-4. doi: 10.2460/ajvr.69.5.670.
8
Single-dose pharmacokinetics of cetirizine in patients with chronic liver disease.西替利嗪在慢性肝病患者中的单剂量药代动力学。
J Clin Pharmacol. 1993 Oct;33(10):929-32. doi: 10.1002/j.1552-4604.1993.tb01924.x.
9
The comparative pharmacokinetics of H1-receptor antagonists.H1受体拮抗剂的比较药代动力学
Ann Allergy. 1987 Dec;59(6 Pt 2):20-4.
10
Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective.左西替利嗪在幼儿中的群体药代动力学:儿科医生的观点。
Pediatr Allergy Immunol. 2005 Mar;16(2):97-103. doi: 10.1111/j.1399-3038.2005.00240.x.

引用本文的文献

1
Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.婴幼儿变应性鼻炎的治疗:第二代抗组胺药和白三烯受体拮抗剂孟鲁司特的疗效和安全性。
Drugs. 2009;69(18):2541-76. doi: 10.2165/9884960-000000000-00000.
2
Second-generation antihistamines: actions and efficacy in the management of allergic disorders.第二代抗组胺药:在过敏性疾病管理中的作用与疗效
Drugs. 2005;65(3):341-84. doi: 10.2165/00003495-200565030-00004.
3
Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years.
6个月至12岁儿童西替利嗪的回顾性群体药代动力学分析。
Br J Clin Pharmacol. 2004 Apr;57(4):402-11. doi: 10.1046/j.1365-2125.2003.02017.x.
4
Cetirizine: a review of its use in allergic disorders.西替利嗪:对其在过敏性疾病中应用的综述。
Drugs. 2004;64(5):523-61. doi: 10.2165/00003495-200464050-00008.
5
Safety of antihistamines in children.抗组胺药在儿童中的安全性。
Drug Saf. 2001;24(2):119-47. doi: 10.2165/00002018-200124020-00003.
6
Cetirizine: a review of its use in children with allergic disorders.西替利嗪:用于儿童过敏性疾病的综述。
Paediatr Drugs. 1999 Jan-Mar;1(1):51-73. doi: 10.2165/00128072-199901010-00005.
7
Clinical pharmacology of new histamine H1 receptor antagonists.新型组胺H1受体拮抗剂的临床药理学
Clin Pharmacokinet. 1999 May;36(5):329-52. doi: 10.2165/00003088-199936050-00003.
8
Pharmacokinetic-pharmacodynamic relationships of H1-antihistamines.H1 抗组胺药的药代动力学-药效学关系。
Clin Pharmacokinet. 1995 May;28(5):419-32. doi: 10.2165/00003088-199528050-00006.